Using this approach, we have shown that the injection of P10-primed MoDC stimulates the proliferation of T CD4+ and T CD8+ lymphocytes and the production of cytokines that are known to favor the control of PCM. The gene discussed is CD4; the disease is paracoccidioidomycosis.